The end of an era: Shall we move forward? Journal Article
| Author: | Dang, C. |
| Article Title: | The end of an era: Shall we move forward? |
| Keywords: | antibiotic agent; overall survival; drug tolerability; doxorubicin; fluorouracil; cancer combination chemotherapy; drug efficacy; side effect; systemic therapy; paclitaxel; cancer adjuvant therapy; disease free survival; methotrexate; multiple cycle treatment; sensory neuropathy; breast cancer; antineoplastic combined chemotherapy protocols; myalgia; epidermal growth factor receptor 2; editorial; cyclophosphamide; receptor, epidermal growth factor; breast neoplasms; high risk patient; docetaxel; febrile neutropenia; breast carcinoma; micrometastasis; epirubicin; recombinant granulocyte colony stimulating factor; hand foot syndrome; antibiotic prophylaxis; congestive heart failure; fluid retention; randomized controlled trial (topic) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 29 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-10-10 |
| Start Page: | 3849 |
| End Page: | 3851 |
| Language: | English |
| DOI: | 10.1200/jco.2011.36.7417 |
| PROVIDER: | scopus |
| PUBMED: | 21911728 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 2 November 2011" - "CODEN: JCOND" - "Source: Scopus" |
